Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Genomics
|
May 23, 1998
A novel long and unstable CAG/CTG trinucleotide repeat on chromosome 17q
T Ikeuchi, K Sanpei, H Takano, et al.
ESMO Open
|
April 19, 2024
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations
J Rodon, E Rodriguez, M L Maitland, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 28, 1998
Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
L N Clark, P Poorkaj, Z Wszolek, et al.
Neurology
|
January 6, 2011
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study
R N Alcalay, A Siderowf, R Ottman, et al.
Parkinsonism & Related Disorders
|
August 23, 2011
The relation between depression and parkin genotype: the CORE-PD study
A Srivastava, M-X Tang, H Mejia-Santana, et al.
Neurology
|
March 24, 2012
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study
R N Alcalay, E Caccappolo, H Mejia-Santana, et al.
The New England Journal of Medicine
|
October 23, 2009
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease
E Sidransky, M A Nalls, J O Aasly, et al.
Nature
|
January 10, 2002
The DNA sequence and comparative analysis of human chromosome 20
P Deloukas, L H Matthews, J Ashurst, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Genomics
|
May 23, 1998
A novel long and unstable CAG/CTG trinucleotide repeat on chromosome 17q
T Ikeuchi, K Sanpei, H Takano, et al.
ESMO Open
|
April 19, 2024
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations
J Rodon, E Rodriguez, M L Maitland, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 28, 1998
Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
L N Clark, P Poorkaj, Z Wszolek, et al.
Neurology
|
January 6, 2011
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study
R N Alcalay, A Siderowf, R Ottman, et al.
Parkinsonism & Related Disorders
|
August 23, 2011
The relation between depression and parkin genotype: the CORE-PD study
A Srivastava, M-X Tang, H Mejia-Santana, et al.
Neurology
|
March 24, 2012
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study
R N Alcalay, E Caccappolo, H Mejia-Santana, et al.
The New England Journal of Medicine
|
October 23, 2009
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease
E Sidransky, M A Nalls, J O Aasly, et al.
Nature
|
January 10, 2002
The DNA sequence and comparative analysis of human chromosome 20
P Deloukas, L H Matthews, J Ashurst, et al.
Page
of 3